Terry's Cellar said...
...Going to the “High Risk” group you can see the success rate of the triple play option is considerably higher than for surgery as a monotherapy....
Men who have a high-grade or very high-risk diagnosis should be told upfront that
surgery monotherapy is not standard of care if their cancer is not prostate-confined. In my case, I was spared both radiation and years of ADT following surgery, because my G9 cancer was prostate-confined (as it appeared to be before surgery). However, my surgeon explained that SOC required that I would need radiation and possibly ADT as part of my primary therapy
if there were negative (adverse) findings in my RP report after the surgery.
**IF** your cancer appeared to be prostate-confined, the chances of surgery (RP)
alone being sufficient to control your cancer would be, perhaps 25-30%.
However, your MRI indicates there is likely EPE and your biopsy cores indicates a rather heavy cancer burden on the right, with lesions all the way from the apex to the base, increasing the risk of seminal vesicle invasion. If you consider surgery, you should ask your docs about
the likelihood of needing radiation and, possibly, ADT afterward
to complete your primary treatment.
The prostatecancerfree.org does not offer studies/statistics for the triple-play therapy of RP+RT+ADT, the surgical counterpart to IMRT+ brachy boost + ADT. IMO comparing RP alone vs. IMRT, brachy boost and ADT does not paint a realistic picture. Men who are very high risk/high grade should stop their primary treatment after RP
only if post-RP conditions permit it.
Your insurance should cover a PSMA-PET scan, given your specific diagnosis. I would ask each doctor you consult with their opinion on a reasonable timeframe for you to make a treatment decision. From what I have read, I wouldn't be surprised if they advise no longer than 4-5 weeks.
Post Edited (DjinTonic) : 4/9/2024 12:55:42 AM (GMT-8)